Clinical Trial Details
— Status: Not yet recruiting
Administrative data
| NCT number |
NCT05549349 |
| Other study ID # |
2022-A00303-40 |
| Secondary ID |
|
| Status |
Not yet recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
October 10, 2022 |
| Est. completion date |
March 10, 2023 |
Study information
| Verified date |
September 2022 |
| Source |
Poissy-Saint Germain Hospital |
| Contact |
Julia Travagli, phD |
| Phone |
+33 1 39 27 40 47 |
| Email |
julia.gross[@]ght-yvelinesnord.fr |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
The main objective of this work is to evaluate the recurrence of biliary episodes before
cholecystectomy (hepatic colic, lithiasic migration, cholangitis, cholecystitis,
pancreatitis, necrosis infections) in patients with acute biliary pancreatitis of any
severity depending on the type of nutrition (oral, enteral or parenteral).
Description:
Acute pancreatitis (AP) is one of the frequent causes of hospitalization in gastroenterology
with an annual incidence of 13-45 cases per 100,000 patients. If we refer to the data in the
white paper, hospitalizations for abdominal emergencies, such as PA, take place in at least
60% of cases in General Hospital Centers (CHG). Among these AP, approximately 40% of AP are
secondary to a biliary lithiasis pathology. The main modalities of the initial management of
AP have been the subject of several national and international recommendations and
consensuses. Although it is well accepted that early refeeding during the first 48 hours
reduces the appearance of a systemic inflammatory response syndrome (SIRS) or a collection
infection, the feeding methods in the event of pancreatitis Acute biliary (ABP) during the
acute phase using the oral route if it is tolerated or the enteral route by nasogastric tube
before cholecystectomy remains debated.
Thus, in case of delayed cholecystectomy after AP, there is no consensus on the feeding
methods after the acute phase (oral or enteral) until cholecystectomy nor on the benefit of a
prophylactic endoscopic sphincterotomy in the absence of cholangitis.
